BUY Piramal Pharma Limited — Nirav Chheda, Nirmal Bang Securities
byNirav Chheda, Nirmal Bang SecuritiesHorizon: NA (inferred Swing (≤2wk))28 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·3 Aug · 2d ago
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·30 Jul · 6d ago
Piramal Pharma narrows Q1 loss as revenue jumps 17%, EBITDA nearly doubles
NewsCnbc-Tv18·29 Jul · 1w ago
Q1 Results Highlights: Piramal Pharma Loss Narrows; Eicher Motors Profit Jumps Over 21%; Waaree Energies Revenue Soars 79%
NewsNdtv-Profit·29 Jul · 1w ago
Piramal Pharma Q1 Results: Net Loss Narrows As Margin Expands; Revenue Up 17%
NewsNdtv-Profit·29 Jul · 1w ago
Buy, Sell Or Hold: Mahindra & Mahindra, UltraTech Cement, Piramal Pharma, Groww And Swiggy — Ask Profit
NewsNdtv-Profit·30 Jul · 6d ago
Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·29 Jul · 1w ago
Piramal Pharma temporarily suspends Ahmedabad plant operations due to heavy rainfall
NewsCnbc-Tv18·25 Jul · 2w ago
Piramal Pharma, Authum Investment, Vaibhav Global Show Technical Breakouts
NewsGoogle News·20 Jul · 2w ago
HDFC Mutual Fund reduces stake in Piramal Pharma by 2.005%
NewsGoogle News·18 Jul · 3w ago
HDFC Mutual Fund ने Piramal Pharma मधील हिस्सा विकला, मोठी घट!
NewsGoogle News·17 Jul · 3w ago
HDFC Mutual Fund Sells 2% Stake in Piramal Pharma
NewsGoogle News·17 Jul · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Piramal Pharma
- BUY — Shrikant Chouhan, Kotak Securities6 Nov 2026 · ~2 weeks · target ₹250 · Active
- BUY — Amol Athawale, Kotak Securities4 Nov 2026 · ~3 months · target ₹270 · Active
- BUY — Rakesh Bansal2 Nov 2026 · ~2 weeks · target ₹267 · Active
- BUY — Kunal Saraogi30 Oct 2026 · ~1 year · target ₹300 · Active
- BUY — ICICI Securities29 Oct 2026 · ~1 year · target ₹290 · Active
More from Nirav Chheda, Nirmal Bang Securities
- BUY NMDC2 Nov 2026 · ~2 weeks · target ₹76 · Active
- BUY Jio Financial Services2 Nov 2026 · ~2 weeks · target ₹225 · Target hit
- BUY Eternal29 Oct 2026 · ~2 weeks · target ₹360 · Target hit
- BUY VA Tech Wabag29 Oct 2026 · ~2 weeks · target ₹1,940 · SL hit
- BUY Power Grid Corporation of India29 Oct 2026 · ~2 weeks · target ₹285 · SL hit

